Periods & Ovulation
Periods & Menstrual Cycle

Tranexamic Acid for Heavy Periods: What to Know

Tranexamic acid is a prescription treatment for heavy menstrual bleeding. Learn how it works, its effectiveness, side effects, and who is a good candidate.

By Fertility & Reproductive Health Editorial Team5 min read
Tranexamic Acid for Heavy Periods: What to Know

Tranexamic acid reduces menstrual blood loss by an average of 40 to 50 percent in women with heavy menstrual bleeding, according to clinical trial data reviewed by the Cochrane Collaboration (Bryant-Smith et al., 2018). The medication is taken only during the days of active bleeding, rather than continuously throughout the cycle, distinguishing it from hormonal treatments.

How It Works

Tranexamic acid belongs to a class of drugs called antifibrinolytics. It works by blocking the breakdown of blood clots within the uterine lining, allowing the body's natural clotting process to reduce bleeding more effectively than it otherwise would. Unlike hormonal treatments, it does not alter the menstrual cycle, prevent ovulation, or affect fertility, since it addresses blood loss directly rather than the hormonal signals driving the period.

Who Might Be Prescribed It

Heavy menstrual bleeding, medically termed menorrhagia, is generally defined as blood loss exceeding 80 milliliters per cycle or bleeding that requires changing a pad or tampon every one to two hours. Tranexamic acid is often considered for individuals who prefer to avoid hormonal contraception, who are trying to conceive and therefore cannot use hormonal treatments, or whose heavy bleeding has an unclear or untreatable underlying cause. Conditions such as uterine fibroids, adenomyosis, and certain bleeding disorders are commonly associated with heavy periods and may prompt a doctor to consider this treatment as part of a broader management plan.

Dosing and Administration

The medication is typically taken as tablets, several times daily, starting at the onset of bleeding and continuing for up to five days or until bleeding substantially decreases. It is not taken during the rest of the cycle, which some patients find preferable to a daily hormonal pill.

Side Effects and Risks

Reported side effects include headache, back pain, and gastrointestinal upset such as nausea or diarrhea, though these tend to be mild in most users. A more serious, though rare, concern involves an increased risk of blood clots, since the medication works by reducing clot breakdown throughout the body, not solely within the uterus. Individuals with a personal or family history of blood clots, stroke, or certain clotting disorders are generally advised against this treatment.

Effectiveness Compared to Other Options

Clinical comparisons have found tranexamic acid roughly as effective as some hormonal treatments for reducing heavy bleeding, though intrauterine devices containing levonorgestrel have shown somewhat greater reductions in blood loss in several head-to-head trials (Bryant-Smith et al., 2018). The choice between these options often comes down to whether hormonal treatment is acceptable to the patient and whether contraception is also a goal.

Helpful answers

Frequently Asked Questions

Quick answers to common questions.

01

Does tranexamic acid affect fertility?

No. It does not suppress ovulation or alter hormone levels, so it has no known effect on fertility.

02

How long does it take to notice a difference in bleeding?

Many users notice reduced bleeding within the first cycle of use, since the medication acts directly during active bleeding rather than requiring weeks to build up in the system.

03

Is tranexamic acid safe to use every month?

It is generally considered safe for repeated monthly use in appropriate candidates, though individuals with clotting risk factors should discuss ongoing use carefully with a physician.

Track It in the App

Tranexamic acid is a prescription treatment and should only be used after appropriate medical assessment.

Author / Research & References

Article Author

Fertility & Reproductive Health Editorial Team

Bryant-Smith AC et al.

Cochrane — Antifibrinolytics for heavy menstrual bleeding

Cochrane systematic review on tranexamic acid for heavy menstrual bleeding

View source

Cochrane Collaboration

Cochrane Library — Antifibrinolytics for heavy menstrual bleeding

Evidence on the effectiveness and safety of antifibrinolytic treatments for heavy menstrual bleeding

View source

American College of Obstetricians and Gynecologists (ACOG)

ACOG — Heavy Menstrual Bleeding

Guidance on heavy menstrual bleeding and treatment options, including tranexamic acid

View source

National Institute for Health and Care Excellence (NICE)

NICE — Heavy menstrual bleeding: assessment and management

Guidance on assessing and managing heavy menstrual bleeding, including tranexamic acid as a non-hormonal treatment option

View source

U.S. Food and Drug Administration (FDA)

FDA — Lysteda (tranexamic acid) prescribing information

Official prescribing information and safety information for tranexamic acid (Lysteda)

View source